SBI Pharma Fund (D) NAV | SBI Mutual Fund | SBI Pharma Fund (D) Investment

MARKET RADAR

SENSEX NIFTY Refresh

You are here : Moneycontrol > Mutual Funds > Sector - Pharma & Healthcare > SBI Mutual Fund > SBI Pharma Fund (D)

SNAPSHOT

SNAPSHOT

Performance

Investment Info

Peers

Portfolio

News and Videos

News Videos

ranking by CRISIL

Not Ranked

This scheme is not ranked by CRISIL.
View Top ranked funds in other categories

Benchmark Index:

View Historic Graph From To

Returns (NAV as on May-23-2013)

Period	Returns (%)	Rank #
1 mth	0.4	3
3 mth	7.0	2
6 mth	10.6	2
1 year	31.4	1
2 year	20.8	1
3 year	18.2	1
5 year	14.6	3

# Moneycontrol Rank within 3 Sector - Pharma & Healthcare Schemes.

Absolute Returns (in %)

Year	Qtr 1	Qtr 2	Qtr 3	Qtr 4	Annual
2013	-3.0	-	-	-	-
2012	9.4	5.5	12.4	6.3	37.3
2011	-6.1	6.8	-8.3	2.9	-5.6
2010	4.8	9.8	-0.3	9.5	29.8
2009	-11.1	43.8	26.2	-0.2	81.4
2008	-27.0	6.7	-10.5	-27.8	-50.2

View where it stands within its peers

* Returns over 1 year are Annualised

Returns Calculator SIP Calculator

EXPAND ALL

Performance

Fund returns v/s Category average (Sector - Pharma & Healthcare)

* Returns over 1 year are Annualised

	1 mth (%)	3 mth (%)	6 mth (%)	1 yr (%)	2 yr (%)	3 yr (%)	5yr (%)
Fund Returns	0.4	7.0	10.6	31.4	20.8	18.2	14.6
Category avg	1.5	7.6	9.5	27.0	15.6	14.9	18.5
Difference of Fund returns and Category returns	-1.1	-0.6	1.1	4.4	5.2	3.3	-3.9
Best of category	2.4	9.5	12.0	31.4	20.8	18.2	24.2
Worst of category	0.4	6.3	5.9	24.1	13.0	12.6	14.6
Benchmark returns #	3.8	10.2	14.8	33.7	21.1	18.8	15.9
Difference of Fund returns and Benchmark returns	-3.4	-3.2	-4.2	-2.3	-0.3	-0.6	-1.3

# Benchmark Index: S&P BSE HEALTHCARE

Investment Info

Investment Objective

To provide the investors maximum growth opportunity through equity investments in stocks of growth oriented sectors of the economy. There are five sub-funds dedicated to specific investment themes viz.Information Technology, Pharmaceuticals,FMCG, Contrarian (investment in stocks currently out of favour) and Emerging Businesses.

Scheme details

Fund Type	Open-Ended
Investment Plan	Dividend
Launch date	Jul 31, 1999
Benchmark	S&P BSE HEALTHCARE
Asset Size (Rs cr)	66.50 (Mar-30-2013)
Minimum Investment	Rs.2000
Last Dividend	Rs.3.90 (Dec-31-2004) View Dividend History
Bonus	N.A.
Fund Manager	Tanmaya Desai View performance of schemes managed by the Fund Manager
Notes	N.A

Load Details

Entry Load	N.A
Exit Load	1.00%
Load Comments	Exit Load 1% if units are redeemed / switched-out within 1 year from the date of allotment.

Contact Details

Regd. Office	191 Maker Towers E, Cuffe Parade, Mumbai, 400005
Tel. No.	91 22 22180221/ 27
Fax No.	91 22 22189663
Email	partnerforlife@sbimf.com
Website	http://www.sbimf.com

Peer Comparison

Sector - Pharma & Healthcare	Crisil Rank	Assets (Rs.cr)
Sector - Pharma & Healthcare	Crisil Rank	Assets (Rs.cr)	3mth (%)	6mth (%)	1yr (%)	3yr (%)	5yr (%)
Reliance Pharma Fund (G)	Not Ranked	652.29	6.3	5.9	24.1	12.6	24.2
SBI Pharma Fund (G)	Not Ranked	66.50	7.0	10.6	31.4	18.2	14.6
UTI Pharma & Health (G)	Not Ranked	103.47	9.5	12.0	25.4	14.0	16.7
* Returns over 1 year are Annualised	More »

Portfolio

Top Holdings (Apr 30, 13)

Equity	Sector	Value (Rs cr)	Asset %
Sun Pharma	Pharmaceuticals	17.12	20.87
Dr Reddys Labs	Pharmaceuticals	11.54	14.06
Cipla	Pharmaceuticals	9.74	11.88
Glenmark	Pharmaceuticals	6.08	7.41
Divis Labs	Pharmaceuticals	5.91	7.20
Wockhardt	Pharmaceuticals	5.71	6.96
Aurobindo Pharm	Pharmaceuticals	3.82	4.65
Alembic Pharma	Pharmaceuticals	2.85	3.48
Lupin	Pharmaceuticals	2.81	3.42
Cadila Health	Pharmaceuticals	2.37	2.89